Clareon TruPlus IOLs for Cataracts

This trial tests new lenses for individuals with cataracts, which are cloudy spots in the eye that affect vision. The trial evaluates the safety and effectiveness of Clareon TruPlus lenses when replacing cloudy lenses during cataract surgery. Two types of lenses are under examination: Clareon TruPlus Monofocal Non-Toric IOL for regular vision correction and Clareon TruPlus Monofocal Toric IOL for correcting astigmatism, a condition where the eye is shaped more like a football than a basketball, causing blurry vision. Individuals with cataracts in both eyes who require surgery in both may be suitable candidates. However, those with other serious eye conditions, such as glaucoma or severe dry eye, are not eligible. As an unphased trial, this study offers an opportunity to contribute to advancing cataract treatment options.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that Clareon TruPlus Monofocal Intraocular Lenses (IOLs) are safe, as indicated by previous studies. These lenses replace the eye's cloudy lens during cataract surgery. One study found that Clareon Monofocal IOLs, similar to the TruPlus version, were effective and safe over a year, with patients experiencing good vision and stable lenses in the eye.

Clareon TruPlus IOLs aim to improve focus while maintaining clear distance vision, enhancing vision without compromising safety. Although new, these lenses are based on the Clareon Monofocal IOLs, already recognized for their safety.

The Clareon TruPlus IOLs are unique because they use advanced optics in both monofocal and toric versions to improve vision clarity for cataract patients. Unlike traditional intraocular lenses, these IOLs are made from a new material that reduces glare and halos, which can significantly enhance night vision. Moreover, the toric version offers precise astigmatism correction, potentially reducing the need for glasses post-surgery. Researchers are excited because these features could lead to better overall visual outcomes and increased patient satisfaction compared to standard IOLs.

Research has shown that Clareon TruPlus Monofocal Intraocular Lenses (IOLs) improve vision after cataract surgery. This trial will evaluate both the Clareon TruPlus Monofocal Non-Toric IOL and the Clareon TruPlus Monofocal Toric IOL. Studies have found that these lenses provide excellent vision for distance and arm's length viewing. Specifically, the TruPlus IOLs enhance visual clarity by about 3.5 letters on an eye chart compared to older models. Patients typically experience minimal lens movement after placement, maintaining stable and clear vision. Additionally, over 99% of patients achieve good vision, enabling clear sight for reading and everyday activities.²³⁴⁶⁷